Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
June 8, 2011 | Journal Article
More stringent evaluation of orphan drug trials is recommended to ensure safety and efficacy.
You are now viewing 1 - 4 of 4 results
June 8, 2011 | Journal Article
More stringent evaluation of orphan drug trials is recommended to ensure safety and efficacy.
October 1, 2010 | Journal Article
As comparative effectiveness research becomes a more prominent feature of clinical medicine, investigators and policy-makers would do well to seek lessons from prior examples of this type of research.
August 19, 2008 | Journal Article
Seeding trials are clinical studies conducted by pharmaceutical companies designed to seem as if they answer a scientific question, but primarily fulfill marketing objectives they have not been described in detail.
January 4, 2011 | Human Capital Blog Post
RWJF Scholars in Health Policy Research National Program Director Alan B. Cohen, Sc.D., had a letter in the December 29, 2010 New York Times (Avastin: Judging the Risks vs. Benefits), noting that Food & Drug Administration (FDA) approval of new drug ...